From: Novel birch pollen specific immunotherapy formulation based on contiguous overlapping peptides
A | |||
---|---|---|---|
Positive skin reactions (≥3 mm wheal and flare present) | |||
Dilutions | |||
1:1 | 1:10 | 1:100 | |
Birch (100’000 SQ) | 20 | 17 | 1 |
r Bet v 1 (1 μM) | 20 | 16 | 2 |
T1 (10 μM) | 0 | 0 | 0 |
T2 (10 μM) | 0 | 0 | 0 |
T3 (10 μM) | 0 | 0 | 0 |
AllerT (10 μM) | 0 | 0 | 0 |
T4 (10 μM) | 0 | 0 | 0 |
T5 (10 μM) | 0 | 0 | 0 |
Mix T4-T5 (10 μM) | 0 | 0 | 0 |
B | |||
0 mm <Skin reaction < 3 mm | |||
Dilutions | |||
1:1 | 1:10 | 1:100 | |
T1 (10 μM) | 2 | 0 | 0 |
T2 (10 μM) | 0 | 0 | 0 |
T3 (10 μM) | 0 | 1 | 0 |
AllerT (10 μM) | 0 | 0 | 0 |
T4 (10 μM) | 0 | 0 | 1 |
T5 (10 μM) | 1 | 0 | 0 |
Mix T4-T5 (10 μM) | 6 | 0 | 1 |